Keratinocyte growth factor enhances urokinase-type plasminogen activator activity in HPV16 DNA-immortalized human uterine exocervical epithelial cells

European Journal of Cell Biology

Volumn 69, Issue 2, 1996, Pages 128-134

  Zheng, Jie ^a   Sirén, Vappu ^a   Vaheri, Antti ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

HPV; Immortalized epithelial cell; Keratinocyte growth factor; Plasminogen activation; Urokinase

Indexed keywords

GROWTH FACTOR RECEPTOR; KERATINOCYTE GROWTH FACTOR; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CELL INVASION; CELL LINE; CELL SECRETION; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECEPTOR BINDING; UTERINE CERVIX EPITHELIUM; UTERUS CARCINOMA;

EID: 0030071813     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Aaronson, S. A., D. P. Bottaro, T. Miki, D. Ron, P. W. Finch, T. P. Fleming, J. Ahn, W. G. Taylor, J. S. Rubin: Keratinocyte growth factor: a fibroblast growth factor family member with unusual target cell specificity. Ann. N. Y. Acad. Sci. 638, 62-77 (1991).
2. Åstedt, B., I. Glifberg, W. Mattsson, C Trope: Arrest of growth of ovarian tumor by tranexamic acid. JAMA 238, 154-155 (1977).
3. Åstedt, B., P. Henriksson, I.-M. Nilsson, L. Svanberg: Regression of hemangioma-thrombocytopenia syndrome. Acta Obstet. Gynecol. Scand. 61, 479-480 (1982).
4. Danø, K., P. A. Andreasen, J. Grøndahl-Hansen, P. Kristensen, L. S. Nielsen, L. Skriver: Plasminogen activators, tissue degradation and cancer. Adv. Cancer Res. 44, 139-266 (1985).
5. Deutsch, D. G., E. T. Mertz: Plasminogen: purification from human plasma by affinity chromatography. Science 170, 1095-1097 (1970).
6. Granelli-Piperno, A., E. Reich: A study of protease and protease-inhibitor complexes in biological fluids. J. Exp. Med. 148, 223-234 (1978).
7. Green, G. D. G., E. Shaw: Thiobenzyl benzyloxycarbonyl-L-lysinate, substrate for a sensitive colorimetric assay for trypsin-like enzymes. Anal. Biochem. 93, 223-226 (1979).
8. Grimaldi, G., P. D. Fiore, E. K. Locatelli, J. Falco, F. Blasi: Modulation of urokinase plasminogen activator gene expression during the transition from quiescent to proliferative state in normal mouse cells. EMBO J. 5, 855-861 (1986).
9. Gross, J. L., D. Moscatelli, E. A. Jaffe, D. B. Rifkin: Plasminogen activator and collagenase production by cultured capillary endothelial cells. J. Cell Biol. 95, 974-981 (1982).
10. Jensen, P. J., M. John, J. Baird, S. Morioka, S. Lessin, G.S. Lazarus: Epidermal plasminogen activator is abnormal in cutaneous lesions. J. Invest. Dermatol. 90, 777-782 (1988).
11. Jensen, P. J., M. John, J. Baird: Urokinase and tissue type plasminogen activators in human keratinocyte culture. Exp. Cell Res. 187, 162-169 (1990).
12. Laemmli, U. K.: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685 (1970)).
13. Lee, L.-S., I. B. Weinstein: Epidermal growth factor, like phorbol esters, induces plasminogen activator in HeLa cells. Nature 274, 696-697 (1978).
14. Newman, M. J., E. A. Lane, M. A. Nugent, E. Racker: Induction of anchorage-independent growth by epidermal growth factor and altered sensitivity to type β transforming growth factor in partially transformed rat kidney cells. Cancer Res. 46, 5842-5850 (1986).
15. Ossowski, L., J. P. Quigley, G. M. Kellerman, E. Reich: Fibrinolysis associated with oncogenic transformation: Requirement of plasminogen for correlated changes in cellular morphology, colony formation in agar, and cell migration. J. Exp. Med. 138, 1056-1064 (1973).
16. Pöllänen, J., O. Saksela, E.-M. Salonen, P. Andreasen, L. S. Nielsen, K. Donø, A. Vaheri: Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells. J. Cell Biol. 104, 1085-1096 (1987).
17. Pöllänen, J., K. Hedman, L. S. Nielsen, K. Danø, A. Vaheri: Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts. J. Cell Biol. 106, 87-95 (1988).
18. Pöllänen, J., R. W. Stephens, A. Vaheri: Directed plasminogen activation at the surface of normal and malignant cells. Adv. Cancer Res. 57, 273-328 (1991).
19. Quigley, J. P.: Phorbol ester-induced morphological changes in transformed chick fibroblasts: Evidence for direct catalytic involvement of plasminogen activator. Cell 17, 131-141 (1979).
20. Rubin, J. S., H. Osada, P. W. Finch, W. G. Taylor, S. Rudikoff, S. A. Aaronson. Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc. Natl. Acad. Sci. USA 86, 802-806 (1989).
21. Salonen, E.-M., A. Vaheri, J. Pöllanen, R. Stephens, P. Andreasen, M. Mayer, K. Danø, J. Gailit, E. Ruoslahti: Interaction of plasminogen activator inhibitor (PAI-1) with vitronectin. J. Biol. Chem. 264, 6339-6343 (1989).
22. Stephens, R., K.-C. Leung, J. Pollänen, E.-M. Salonen, A Vaheri: Microplate immunocapture assay for plasminogen activators and their specific inhibitors. J. Immunol. Methods 105, 245-251 (1987).
23. Stoker, M., E. Gherardi: Regulation of cell movement: the motogenic cytokines. Biochim. Biophys. Acta 1072, 81-101 (1991).
24. Tsuboi, R., C. Sato, Y. Kurita, D. Ron, J. S. Rubin, H. Ogawa: Keratinocyte growth factor (FGF-7) stimulates migration and plasminogen activator activity of normal human keratinocytes. J. Invest Dermatol. 101, 49-53 (1993).
25. Verde, P., M. P. Stoppelli, P. Galeffi, P. Di. Nocera, F. Blasi: Identification and primary sequence of an unspliced human urokinase poly (A)- RNA. Proc. Natl. Acad. Sci. USA 81, 4727 (1984).
26. Werb, Z., M. J. Banda, P. A. Jones: Degradation of connective tissue matrices by macrophages. I. Proteolysis of elastin, glycoproteins, and collagen by proteinases isolated from macrophages. J. Exp. Med. 152, 1340-1357 (1980).
27. Werner, S., K. G. Peters, M. T. Longaker, F. Fuller-Pace, M. J. Banda, L. T. Williams: Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc. Natl. Acad. Sci USA 89, 6896-6900 (1992).
28. Wright, J. A., E. A. Turley, A. H. Greenberg: Transforming growth factor beta and fibroblast growth factor as promoter of tumor progression to malignancy. Crit. Rev. Oncogenesis 4, 473-492 (1993).
29. Zheng, J., T. Wahlström, J. Paavonen, A. Vaheri: Altered growth behavior of human cervical epithelial cells transfected by HPV type 16 and 18 DNA. Int. J. Cancer 58, 713-720 (1994).
30. Zheng, J., A. Vaheri: Human skin fibroblast induce anchorage-independent growth of HPV 16 DNA-immortalized cervical epithelial cells. Int. J. Cancer 61, 658-665, (1995).
31. Zheng, J., O. Saksela, S. Matikainen, A Vaheri: Keratinocyte growth factor is a bifunctional regulator of HPV16 DNA-immortalized cervical epithelial cells. J. Cell Biol. 129, 843-851 (1995).